SynCore Biotechnology Co Ltd Cash Flow Quality Index

Latest as of December 2023: -0.72x

SynCore Biotechnology Co Ltd cash flow quality index. SynCore Biotechnology Co Ltd (4192) has a Cash Flow Quality Index of -0.72x as of December 2023. Operating cash flow of NT$-30.14 Million is below net income of NT$41.62 Million, suggesting accrual-heavy earnings not yet converted to cash. See 4192 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.72x
Operating CF / Net Income

Operating Cash Flow

NT$-30.14 Million
TWD

Net Income

NT$41.62 Million
TWD

Data as of

Dec 2023
Most recent filing

SynCore Biotechnology Co Ltd Cash Flow Quality Index by Year (None–None)

SynCore Biotechnology Co Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for SynCore Biotechnology Co Ltd. For the full cash flow conversion analysis, see SynCore Biotechnology Co Ltd cash flow conversion.

Year Quality Index Operating CF (TWD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.